108
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Relationship Between Bone Metabolism and Peripheral Artery Disease in Patients on Hemodialysis: The Potential Role of Osteocalcin

, , &
Pages 3331-3337 | Received 25 Aug 2023, Accepted 10 Oct 2023, Published online: 26 Oct 2023

References

  • Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–1340. doi:10.1016/S0140-6736(13)61249-0
  • Writing Committee M, Gerhard-Herman MD, Gornik HL, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Vasc Med. 2017;22(3):NP1–NP43. doi:10.1177/1358863X17701592
  • Abola MTB, Golledge J, Miyata T, et al. Asia-Pacific consensus statement on the management of peripheral artery disease: a report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee. J Atheroscler Thromb. 2020;27(8):809–907. doi:10.5551/jat.53660
  • Aktas G, Yilmaz S, Kantarci DB, et al. Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury? Postgrad Med. 2023;135(5):519–523. doi:10.1080/00325481.2023.2214058
  • Tekce H, Kin tekce B, Aktas G, Tanrisev M, Sit M. The evaluation of red cell distribution width in chronic hemodialysis patients. Int J Nephrol. 2014;2014:754370. doi:10.1155/2014/754370
  • Rajagopalan S, Dellegrottaglie S, Furniss AL, et al. Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation. 2006;114(18):1914–1922. doi:10.1161/CIRCULATIONAHA.105.607390
  • Villain C, Ecochard R, Bouchet JL, et al. Relative prognostic impact of nutrition, anaemia, bone metabolism and cardiovascular comorbidities in elderly haemodialysis patients. Nephrol Dial Transplant. 2019;34(5):848–858. doi:10.1093/ndt/gfy272
  • Ambur V, Park P, Gaughan JP, et al. The impact of chronic kidney disease on lower extremity bypass outcomes in patients with critical limb ischemia. J Vasc Surg. 2019;69(2):491–496. doi:10.1016/j.jvs.2018.05.229
  • Ghimire M, Pahari B, Das G, Sharma SK, Das GC. Prevalence of Peripheral Arterial Disease (PAD) in End Stage Renal Disease (ESRD) patients on hemodialysis: a study from central Nepal. Kathmandu Univ Med J. 2014;12(47):181–184. doi:10.3126/kumj.v12i3.13714
  • Kaminski MR, Raspovic A, McMahon LP, et al. Factors associated with foot ulceration and amputation in adults on dialysis: a cross-sectional observational study. BMC Nephrol. 2017;18(1):293. doi:10.1186/s12882-017-0711-6
  • Arroyo D, Betriu A, Valls J, et al. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study. Nephrol Dial Transplant. 2017;32(3):513–520. doi:10.1093/ndt/gfw039
  • Asceric RR, Dimkovic NB, Trajkovic GZ, et al. Prevalence, clinical characteristics, and predictors of peripheral arterial disease in hemodialysis patients: a cross-sectional study. BMC Nephrol. 2019;20(1):281. doi:10.1186/s12882-019-1468-x
  • Lin WC, Tsai JP, Lai YH, et al. Serum osteoprotegerin level is positively associated with peripheral artery disease in patients with peritoneal dialysis. Ren Fail. 2020;42(1):131–136. doi:10.1080/0886022X.2020.1714654
  • Tian SL, Zhang K, Xu PC. Increased prevalence of peripheral arterial disease in patients with obese sarcopenia undergoing hemodialysis. Exp Ther Med. 2018;15(6):5148–5152. doi:10.3892/etm.2018.6002
  • Vuruşkan E, Saraçoğlu E, Küçükosmanoğlu M, Yavuz F, Kuzu Z, Sincer İ. Emergency endovascular treatment of peripheral arterial injuries occurring during the Syrian civil war: gaziantep Dr. Ersin Arslan Education and Research Hospital Experience. Anatol J Cardiol. 2016;16(4):298–304.
  • Rivero M, Nader ND, Blochle R, Harris LM, Dryjski ML, Dosluoglu HH. Poorer limb salvage in African American men with chronic limb ischemia is due to advanced clinical stage and higher anatomic complexity at presentation. J Vasc Surg. 2016;63(5):1318–1324. doi:10.1016/j.jvs.2015.11.052
  • Higashitani M, Uemura Y, Mizuno A, et al. Cardiovascular outcome and mortality in patients undergoing endovascular treatment for symptomatic peripheral artery disease- short-term results of the Toma-Code Registry. Circ J. 2018;82(7):1917–1925. doi:10.1253/circj.CJ-18-0105
  • Norvell DC, Thompson ML, Boyko EJ, et al. Mortality prediction following non-traumatic amputation of the lower extremity. Br J Surg. 2019;106(7):879–888. doi:10.1002/bjs.11124
  • Smith SL, Matthews EO, Moxon JV, Golledge J. A systematic review and meta-analysis of risk factors for and incidence of 30-day readmission after revascularization for peripheral artery disease. J Vasc Surg. 2019;70(3):996–1006 e7. doi:10.1016/j.jvs.2019.01.079
  • Ko T, Higashitani M, Uemura Y, et al. Clinical outcome and diverse risk factors for different therapeutic target locations of peripheral artery disease. J Atheroscler Thromb. 2020;27(8):769–779. doi:10.5551/jat.52647
  • Huang HL, Jimmy Juang JM, Chou HH, et al. Immediate results and long-term cardiovascular outcomes of endovascular therapy in octogenarians and nonoctogenarians with peripheral arterial diseases. Clin Interv Aging. 2016;11:535–543. doi:10.2147/CIA.S106119
  • Huang HL, Tzeng IS, Chou HH, et al. Contemporary cardiovascular outcomes in Taiwanese patients undergoing endovascular therapy for symptomatic lower extremity peripheral arterial disease. J Formos Med Assoc. 2020;119(6):1052–1060. doi:10.1016/j.jfma.2019.10.011
  • Otte J, van Netten JJ, Woittiez AJ. The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation. J Vasc Surg. 2015;62(2):406–411. doi:10.1016/j.jvs.2015.02.051
  • Bourrier M, Ferguson TW, Embil JM, Rigatto C, Komenda P, Tangri N. Peripheral artery disease: its adverse consequences with and without CKD. Am J Kidney Dis. 2020;75(5):705–712. doi:10.1053/j.ajkd.2019.08.028
  • Moussa Pacha H, Al-Khadra Y, Darmoch F, et al. In-hospital outcome of peripheral vascular intervention in dialysis-dependent end-stage renal disease patients. Catheter Cardiovasc Interv. 2020;95(3):E84–E95. doi:10.1002/ccd.28522
  • Anantha-Narayanan M, Sheikh AB, Nagpal S, et al. Systematic review and meta analysis of outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end stage renal disease. J Vasc Surg. 2020;73(1):331–340.e4. doi:10.1016/j.jvs.2020.08.032
  • Kaminski MR, Lambert KA, Raspovic A, et al. Risk factors for foot ulceration in adults with end-stage renal disease on dialysis: a prospective observational cohort study. BMC Nephrol. 2019;20(1):423. doi:10.1186/s12882-019-1594-5
  • Raikou VD, Kyriaki D. Factors related to peripheral arterial disease in patients undergoing hemodialysis: the potential role of monocyte chemoattractant protein-1. Hypertens Res. 2019;42(10):1528–1535. doi:10.1038/s41440-019-0259-x
  • Iannuzzo G, Forte F, Lupoli R, Di Minno MND. Association of Vitamin D deficiency with peripheral arterial disease: a meta-analysis of literature studies. J Clin Endocrinol Metab. 2018;103(6):2107–2115.
  • Wang Y, Feng T, Zhou H, Lu K, Bai Y, Zhang P. Vitamin D deficiency may not be an independent risk factor for peripheral arterial disease in middle-aged and elderly patients with type 2 diabetes in China. Dis Markers. 2020;2020:8854717. doi:10.1155/2020/8854717
  • Hsu YH, Yu HY, Chen HJ, Li TC, Hsu CC, Kao CH. The risk of peripheral arterial disease after parathyroidectomy in patients with end-stage renal disease. PLoS One. 2016;11(6):e0156863. doi:10.1371/journal.pone.0156863
  • Laucyte-Cibulskiene A, Petraviciute M, Gudynaite M, et al. Mismatch between stiffness in elastic and muscular arteries as a predictor of vascular calcification in dialysis patients. Aging Clin Exp Res. 2018;30(4):375–382. doi:10.1007/s40520-017-0787-7
  • Ishii T, Takabe S, Yanagawa Y, et al. Laser Doppler blood flowmeter as a useful instrument for the early detection of lower extremity peripheral arterial disease in hemodialysis patients: an observational study. BMC Nephrol. 2019;20(1):470. doi:10.1186/s12882-019-1653-y
  • Wang JS, Mazur CM, Wein MN. Sclerostin and osteocalcin: candidate bone-produced hormones. Front Endocrinol. 2021;12:584147. doi:10.3389/fendo.2021.584147
  • Berger JM, Karsenty G. Osteocalcin and the physiology of danger. FEBS Lett. 2022;596(5):665–680. doi:10.1002/1873-3468.14259
  • Wu J, Dou Y, Liu W, Zhao Y, Liu X. Osteocalcin improves outcome after acute ischemic stroke. Aging. 2020;12(1):387–396. doi:10.18632/aging.102629
  • Han KH, Hennigar RA, O’Neill WC. The association of bone and osteoclasts with vascular calcification. Vasc Med. 2015;20(6):527–533. doi:10.1177/1358863X15597076
  • Rashdan NA, Sim AM, Cui L, et al. Osteocalcin regulates arterial calcification via altered wnt signaling and glucose metabolism. J Bone Miner Res. 2020;35(2):357–367. doi:10.1002/jbmr.3888
  • Xia LM, Zhang AP, Zheng Q, et al. Quercetin‑3‑O‑β‑D‑glucuronide inhibits mitochondria pathway‑mediated platelet apoptosis via the phosphatidylinositol‑3‑kinase/AKT pathway in immunological bone marrow failure. World J Tradit Chin Med. 2022;8(1):115–122. doi:10.4103/wjtcm.wjtcm_44_21